Therefore, G-NK cells could be used as a potential immunotherapy for HCC patients who were diagnosed GPC3+ by immunohistochemistry; and (iv) The G-NK cells were biocompatible with no obvious in vivo cytotoxicity. Here, GPC3 is linked to hepatocellular carcinoma.